Abstract
For many years, glial cells from the central nervous system have been considered as support cells involved in the homeostasis of the brain. However, a series of key-findings obtained during the past two decades has put light on unexpected roles for glia and it is getting more and more admitted that glia play an active role in several physiological functions. The discovery that a bidirectional communication takes place between astrocytes (the star shaped glial cell of the brain) and neurons, was a major breakthrough in the field of synaptic physiology. Astrocytes express receptors that get activated by neurotransmitters during synaptic transmission. In turn they release other transmitters - called gliotransmitters - that bind to neuronal receptors and modulate synaptic transmission. This feedback, which led to the concept of the tripartite synapse, has been reported with various transmitters including glutamate, ATP, GABA or serine. In the present review we will focus on astrocytes and review the evidence suggesting and demonstrating their role in motor control.
Rhythmic motor behaviors such as locomotion, swimming or chewing are generated by networks of neurons termed central pattern generators (CPG). These networks are highly flexible and adjust the frequency of their output to the external environment. In the case of respiration, the CPG reacts when changes in the pH of the blood occur. The chemosensory control of breathing is ensured by astrocytes, which react to variation of the blood pH by releasing ATP on neurons that in turn adapt the frequency of respiration. In the spinal cord, diverse transmitters such as ATP, adenosine or endocannabinoids modulate the CPG responsible for locomotion. A growing body of evidence suggests that glial cells release some of these molecules. These data suggest that astrocytes play an essential role in motor control and we believe that a range of studies will confirm this view in the near future.
Keywords: Astrocyte, locomotion, respiration, spinal cord, gliotransmitter, glutamate, adenosine, ATP.
Current Pharmaceutical Design
Title:How do Glial Cells Contribute to Motor Control?
Volume: 19 Issue: 24
Author(s): Rasmus K. Christensen, Anders Victor Petersen and Jean-Francois Perrier
Affiliation:
Keywords: Astrocyte, locomotion, respiration, spinal cord, gliotransmitter, glutamate, adenosine, ATP.
Abstract: For many years, glial cells from the central nervous system have been considered as support cells involved in the homeostasis of the brain. However, a series of key-findings obtained during the past two decades has put light on unexpected roles for glia and it is getting more and more admitted that glia play an active role in several physiological functions. The discovery that a bidirectional communication takes place between astrocytes (the star shaped glial cell of the brain) and neurons, was a major breakthrough in the field of synaptic physiology. Astrocytes express receptors that get activated by neurotransmitters during synaptic transmission. In turn they release other transmitters - called gliotransmitters - that bind to neuronal receptors and modulate synaptic transmission. This feedback, which led to the concept of the tripartite synapse, has been reported with various transmitters including glutamate, ATP, GABA or serine. In the present review we will focus on astrocytes and review the evidence suggesting and demonstrating their role in motor control.
Rhythmic motor behaviors such as locomotion, swimming or chewing are generated by networks of neurons termed central pattern generators (CPG). These networks are highly flexible and adjust the frequency of their output to the external environment. In the case of respiration, the CPG reacts when changes in the pH of the blood occur. The chemosensory control of breathing is ensured by astrocytes, which react to variation of the blood pH by releasing ATP on neurons that in turn adapt the frequency of respiration. In the spinal cord, diverse transmitters such as ATP, adenosine or endocannabinoids modulate the CPG responsible for locomotion. A growing body of evidence suggests that glial cells release some of these molecules. These data suggest that astrocytes play an essential role in motor control and we believe that a range of studies will confirm this view in the near future.
Export Options
About this article
Cite this article as:
Christensen K. Rasmus, Petersen Victor Anders and Perrier Jean-Francois, How do Glial Cells Contribute to Motor Control?, Current Pharmaceutical Design 2013; 19 (24) . https://dx.doi.org/10.2174/13816128113199990384
DOI https://dx.doi.org/10.2174/13816128113199990384 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Potential Benefits of Glitazones for Cancer and Vascular Disease
Current Drug Therapy CDK-associated Cullin 1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Human Glioblastoma
Current Cancer Drug Targets Small Molecules with EGFR-TK Inhibitor Activity
Current Drug Targets Cigarette Smoke Decreases Salivary 18 kDa Translocator Protein Binding Affinity – in Association with Oxidative Stress
Current Medicinal Chemistry Transcriptional Analysis of JAK/STAT Signaling in Glioblastoma Multiforme
Current Pharmacogenomics and Personalized Medicine Refractory Angina Pectoris: Lessons from the Past and Current Perspectives
Current Pharmaceutical Design Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation
Current Cancer Drug Targets Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics
Anti-Cancer Agents in Medicinal Chemistry Genetic and Epigenetic Studies for Determining Molecular Targets of Natural Product Anticancer Agents
Current Cancer Drug Targets Multivariate Statistical Tools for the Evaluation of Proteomic 2D-maps:Recent Achievements and Applications
Current Proteomics Combinations of Plant Polyphenols & Anti-Cancer Molecules: A Novel Treatment Strategy for Cancer Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Biodistribution and Safety Assessment of Bladder Cancer Specific Recombinant Oncolytic Adenovirus in Subcutaneous Xenografts Tumor Model in Nude Mice
Current Gene Therapy Looking out for Cancer Stem Cells’ Properties: The Value-Driving Role of CD44 for Personalized Medicines
Current Cancer Drug Targets Modulation of Tumour-Related Signaling Pathways by Natural Pentacyclic Triterpenoids and their Semisynthetic Derivatives
Current Medicinal Chemistry P2Y Receptor Activation Affects the Proliferation and Differentiation of Glial and Neuronal Cells: A Focus on Rat C6 Glioma Cells
Current Neuropharmacology Recent Advances in Antabuse (Disulfiram): The Importance of its Metal-binding Ability to its Anticancer Activity
Current Medicinal Chemistry Matrix Metalloproteinases: Drug Targets for Myocardial Infarction
Current Drug Targets Small Molecular Inhibitors Targeting Chromatin Regulating Proteins for Cancer
Current Protein & Peptide Science Nanomedicine to Overcome Cancer Multidrug Resistance
Current Drug Metabolism Modulation of Carbonic Anhydrase 9 (CA9) in Human Brain Cancer
Current Pharmaceutical Design